wide complex tachycardia
Recently Published Documents


TOTAL DOCUMENTS

322
(FIVE YEARS 70)

H-INDEX

14
(FIVE YEARS 1)

Heart Rhythm ◽  
2022 ◽  
Vol 19 (1) ◽  
pp. 167-168
Author(s):  
Anna Sarcon ◽  
Eunjeong Kim ◽  
David G. Rosenthal ◽  
Melvin M. Scheinman


Circulation ◽  
2021 ◽  
Vol 144 (25) ◽  
pp. 2040-2042
Author(s):  
Andrés F. Miranda-Arboleda ◽  
Shireen Mohammad ◽  
Adrian Baranchuk


Author(s):  
Shivank Gupta ◽  
Ashutosh Yadav ◽  
Anunay Gupta


Author(s):  
Anthony H. Kashou ◽  
Sarah LoCoco ◽  
Trevon D. McGill ◽  
Christopher M. Evenson ◽  
Abhishek J. Deshmukh ◽  
...  


Author(s):  
János Tomcsányi ◽  
Emil Toldy-Schedel ◽  
Péter Arányi


2021 ◽  
Vol 3 (11) ◽  
pp. 1396-1397
Author(s):  
Ana de Leon ◽  
Adrian Baranchuk ◽  
Andres Enriquez


2021 ◽  
Vol 5 (9) ◽  
Author(s):  
Stefan Preisendörfer ◽  
Gabriele Hessling ◽  
Isabel Deisenhofer ◽  
Felix Bourier

Abstract Background Wide complex tachycardia (WCT) associated with syncope as manifestation of an underlying, life-threatening arrhythmia might potentially be the harbinger of sudden cardiac death. Identifying the aetiology of a WCT is imperative to provide appropriate treatment and prevent recurrence. Case summary We report the case of a 22-year-old male who had been experiencing haemodynamically significant WCT leading to syncope at the age of 13 years. As the patient and the family rejected an electrophysiological (EP) study, he had received an implantable cardioverter-defibrillator (ICD) for secondary prevention. After 7 years of experiencing multiple shocks, the patient finally gave consent to an EP study, which identified a left-sided accessory atrioventricular pathway that was successfully ablated during the same procedure. Discussion The differential diagnosis of WCT might be challenging and includes both ventricular and supraventricular tachycardias. In young patients without structural heart disease experiencing WCT, an EP study should be offered before ICD implantation to make a final diagnosis with the potential to provide definitive treatment.



2021 ◽  
Vol 3 (11) ◽  
pp. 1373-1375
Author(s):  
Marco Bergonti ◽  
Ciro Ascione ◽  
Claudio Tondo ◽  
Andrea Sarkozy


Sign in / Sign up

Export Citation Format

Share Document